The US Food and Drug Administration (FDA) recently granted approval for the ReShape Integrated Dual Balloon System (ReShape Dual Balloon) to treat obese adults without the need for invasive surgery.
The majority of hospitals included in a recent analysis use reusable sharp containers, a practice that is linked to higher incidence of Clostridium difficile (C. diff) infection.
Study shows that adalimumab led to sustained clinical and functional responses in nearly one-third of treatment-refractory patients who completed 10 years of treatment. Patients with shorter disease duration achieved better outcomes, highlighting the need for early treatment.
Patients with chronic back and leg pain may be able to forgo the use of prescription painkillers thanks to a new treatment that has been shown to provide long-lasting analgesia.
Americans undergo approximately 90,0000 ventral hernia repairs annually. Those who contract methicillin-resistant staphylococcus aureus infections face a difficult course, and clinicians often struggle to eradicate this tenacious infection.
Calling dermatology the study of the skin only begins to scratch the surface of the field. While environmental factors have been thoroughly looked at, advancements in technology are allowing doctors and researchers to look for deeper issues affecting their patients.
The latest research has confirmed bariatric surgery or lifestyle modifications could significantly diminish levels of nonalcoholic steatohepatitis (NASH) in obese patients.
Unless a vaccine is considered “perfect”, it could be causing more harm than good.
At least 5 studies indicating that testosterone replacement therapy either has no effect on cardiovascular health -- or tends to improve it -- appeared during the 3-week period immediately after the US Food and Drug Administration's controversial decision to mandate warnings about the potential cardiovascular risks of such treatment.